Focal Therapy for Prostate Cancer: Is It Being Oversold?
Despite growing enthusiasm for this minimally invasive option for some men with prostate cancer, focal therapy is still not FDA-approved for prostate cancer and comes with high out-of-pocket costs.
Medscape Medical News
source https://www.medscape.com/viewarticle/focal-therapy-prostate-cancer-evidence-based-or-oversold-2024a10003do?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/focal-therapy-prostate-cancer-evidence-based-or-oversold-2024a10003do?src=rss
Comments
Post a Comment